V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214093 | 20129671 | 1.71 | null | Adjuvant (A) | 2021-01-26 | 2021-02-11 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100660656 |
| 20214095 | 20129672 | 1.81 | 55 | Palliative (P) | 2020-10-21 | 2020-10-21 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100250165 |
| 20214096 | 20129673 | 1.58 | 83.1 | Curative (C) | 2017-10-24 | 2017-10-28 | Sorafenib | 02 | Y | SORAFENIB | 100042053 |
| 20214099 | 20129674 | 1.66 | 88.6 | Palliative (P) | 2018-11-12 | 2018-11-19 | GO2 TRIAL | 01 | N | TRIAL | 100584104 |
| 20214100 | 20129675 | 1.57 | 61.9 | Palliative (P) | null | 2017-10-31 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101793730 |
| 20214101 | 20129676 | 1.7 | 88 | 03 | 2019-01-05 | 2019-01-08 | Trial Unspecified | 2 | N | TRIAL | 100629541 |
| 20214102 | 20129677 | 1.63 | 69.1 | null | null | 2012-07-29 | Trial Unspecified | N | null | TRIAL | 100134483 |
| 20214104 | 20129678 | 1.78 | 0 | Palliative (P) | 2021-04-09 | 2021-04-12 | Sorafenib | 2 | N | SORAFENIB | 101333637 |
| 20214109 | 20129679 | null | 82.3 | Palliative (P) | 2019-04-01 | 2019-04-17 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100062839 |
| 20214110 | 20129680 | 0 | 66 | Palliative (P) | 2021-01-01 | 2021-01-02 | EOX | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100238583 |
| 20214111 | 20129681 | 1.88 | 111.85 | Palliative (P) | 2017-06-11 | 2017-06-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101210760 |
| 20214112 | 20129682 | 1.68 | 68.5 | Palliative (P) | 2019-08-28 | 2019-08-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | EOX | 100119981 |
| 20214114 | 20129683 | 1.74 | 94.1 | Palliative (P) | 2018-06-14 | 2018-06-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101296524 |
| 20214115 | 20129684 | 1.81 | null | Palliative (P) | 2020-05-10 | 2020-05-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100375995 |
| 20214116 | 20129685 | 1.6 | 79 | null | 2016-05-27 | 2016-05-27 | Sorafenib | 99 | null | SORAFENIB | 100011439 |
| 20214117 | 20129686 | 1.71 | 116.9 | Curative (C) | 2017-12-21 | 2018-01-15 | Trial Unspecified | 02 | Y | TRIAL | 101422466 |
| 20214118 | 20129687 | 1.75 | 83.1 | Palliative (P) | 2018-02-04 | 2018-02-26 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101749081 |
| 20214120 | 20129688 | 1.86 | 58.4 | Palliative (P) | 2019-03-18 | 2019-06-10 | Sorafenib | N | N | SORAFENIB | 100552320 |
| 20214121 | 20129689 | 1.77 | 78.4 | Palliative (P) | 2019-08-22 | 2019-09-17 | CAPECITABINE + RT | null | N | CAPECITABINE + RT | 100736965 |
| 20214122 | 20129690 | 1.59 | 59.2 | Palliative (P) | 2018-10-08 | 2018-10-08 | EOX | N | N | CAPECITABINE + RT | 100718454 |
| 20214123 | 20129691 | 1.7 | 71.1 | null | 2019-07-19 | 2019-07-28 | EOX | 02 | null | TRIAL | 101102612 |
| 20214124 | 20129692 | 0 | 80 | Palliative (P) | 2020-01-25 | 2020-09-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100931845 |
| 20214126 | 20129693 | 1.68 | 86 | Palliative (P) | 2018-03-05 | 2018-03-05 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101814116 |
| 20214129 | 20129694 | 1.75 | 66.05 | Palliative (P) | 2020-07-03 | 2020-08-03 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100041702 |
| 20214130 | 20129695 | 1.64 | 88 | Curative (C) | 2020-01-13 | 2020-11-03 | EOX | 02 | Y | SORAFENIB | 100660410 |
| 20214132 | 20129696 | 1.78 | 50 | null | 2020-11-15 | 2020-12-14 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101682956 |
| 20214133 | 20129697 | 1.63 | 55.3 | Palliative (P) | 2020-01-11 | 2020-04-20 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100855387 |
| 20214135 | 20129698 | 1.7 | 61 | Palliative (P) | 2019-03-17 | 2019-10-13 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101531698 |
| 20214136 | 20129699 | 1.85 | 86 | Palliative (P) | 2018-11-16 | 2018-11-23 | Capecitabine 5days + RT | N | N | CAPECITABINE + RT | 100047833 |
| 20214138 | 20129700 | 1.75 | 103 | 03 | 2020-02-23 | 2020-03-17 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101482805 |
| 20214139 | 20129701 | 1.67 | 100 | Adjuvant (A) | 2018-06-23 | 2018-07-07 | Trial Unspecified | 1 | N | TRIAL | 100879164 |
| 20214140 | 20129702 | 1.92 | 98.1 | null | 2016-03-04 | 2016-05-27 | EOX | 02 | N | SORAFENIB | 100828958 |
| 20214141 | 20129703 | 1.82 | 57.8 | Palliative (P) | 2018-02-23 | 2018-03-11 | Cetuximab + FOLFIRI cycle 2 onwards | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 100919473 |
| 20214143 | 20129704 | 1.62 | 70 | Neo-adjuvant (N) | null | 2018-05-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101143328 |
| 20214144 | 20129705 | 1.79 | 67 | Palliative (P) | 2018-01-18 | 2018-01-26 | EOX | 02 | N | EOX | 101546655 |
| 20214148 | 20129706 | 1.64 | 65.4 | Palliative (P) | 2018-02-23 | 2018-02-26 | EOX | 02 | null | EOX | 101849684 |
| 20214149 | 20129707 | 1.75 | 72.4 | Palliative (P) | 2019-01-29 | 2019-02-09 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101641037 |
| 20214151 | 20129708 | 1.6 | 114 | Curative (C) | 2018-01-08 | 2018-03-25 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 101252201 |
| 20214152 | 20129709 | 1.85 | 54 | Palliative (P) | 2018-06-19 | 2018-06-19 | Trial Unspecified | 02 | N | OXALIPLATIN + RALTITREXED | 100795067 |
| 20214153 | 20129710 | 1.7 | 45 | Palliative (P) | 2019-09-27 | 2019-10-06 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101302666 |
| 20214154 | 20129711 | 1.72 | 107 | Palliative (P) | 2019-03-30 | 2019-04-11 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100412874 |
| 20214157 | 20129712 | 1.72 | 62.6 | Neo-adjuvant (N) | 2017-03-30 | 2017-05-12 | Trial Unspecified | 02 | N | TRIAL | 101583314 |
| 20214158 | 20129713 | 1.56 | 70 | Palliative (P) | 2019-12-13 | 2020-02-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100448634 |
| 20214159 | 20129714 | 1.67 | 60.1 | Palliative (P) | 2020-02-10 | 2021-04-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100434790 |
| 20214160 | 20129715 | 1.78 | 80.8 | Neo-adjuvant (N) | 2018-03-04 | 2018-03-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101779126 |
| 20214165 | 20129716 | 1.66 | 77.4 | null | null | 2016-06-09 | EOX | 2 | null | OXALIPLATIN + RALTITREXED | 101599876 |
| 20214166 | 20129717 | 1.78 | 67.5 | Curative (C) | 2017-06-29 | 2017-06-29 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100353394 |
| 20214168 | 20129718 | 1.75 | 63.2 | Neo-adjuvant (N) | 2020-08-24 | 2020-08-30 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100670210 |
| 20214169 | 20129719 | 1.81 | 73.4 | Curative (C) | 2019-06-15 | 2019-06-23 | Trial Unspecified | 02 | Y | TRIAL | 101598403 |
| 20214170 | 20129720 | 1.64 | 69.5 | Neo-adjuvant (N) | 2019-06-16 | 2019-11-13 | EOX | 02 | N | SORAFENIB | 101186962 |